FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine Clinical Trials In-Vitro Protein Trials 
XTalks
SEPTEMBER 14, 2020
“Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Moderna’s COVID-19 Vaccine.
The Pharma Data
MAY 4, 2021
to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. First-Quarter 2021 Revenues of $14.6 EXECUTIVE COMMENTARY.
Expert insights. Personalized for you.
92 
Let's personalize your content